Volume 20, Number 8—August 2014
CME ACTIVITY - Synopsis
Leptospirosis-Associated Hospitalizations, United States, 1998–2009
Table 2
Numbers of leptospirosis-associated and nonleptospirosis infectious disease–associated hospitalizations by selected variables, United States, 1998–2009
| Variable, characteristic | Median no. (25th, 75th quartiles) hospitalizations |
|---|---|
| Patient age, y | |
| Infection type | |
| Leptospirosis-associated | 42.1 (27.8, 57.4) |
| Nonleptospirosis infectious disease | 56.4 (30.4, 76.2) |
| Sex of patient | |
| M | 40.8 (27.0, 55.4) |
| F |
44.2 (30.2, 60.6) |
| Length of hospital stay, d, by hospitalization type | |
| Leptospirosis-associated | 4.1 (2.4, 7.5) |
| Nonleptospirosis infectious disease–associated |
3.3 (1.7, 6.0) |
| Hospital charges, US dollars, by leptospirosis-associated hospitalizations | |
| Total | 19,768 (10,444, 37,422) |
| Sex of patient | |
| M | 18,577 (11,161, 34,855) |
| F | 24,093 (9,279, 44,960) |
| Patient age group, y | |
| <20 | 17,815 (9,253, 33,780) |
| 20–59 | 18,942 (10,700, 35,046) |
| >60 | 24,578 (10,230, 58,103) |
1These authors contributed equally to this article.
Page created: July 17, 2014
Page updated: July 17, 2014
Page reviewed: July 17, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.